BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18316953)

  • 1. Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials.
    Wang T; Zhang X; Zhou N; Shen Y; Li B; Chen BE; Li X
    J Am Heart Assoc; 2023 Jun; 12(11):e029512. PubMed ID: 37264945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flash'O real-world evidence programme - Attitude and practices toward the use of omega-3 FA by physicians from Middle East Countries.
    Kinsara AJ; Sabbour H
    Medicine (Baltimore); 2023 Oct; 102(40):e35416. PubMed ID: 37800826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish-Derived Omega-3 Fatty Acids: Guardians of High-Density Lipoprotein?
    Toh R
    J Atheroscler Thromb; 2023 Aug; 30(8):855-858. PubMed ID: 37032090
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence on Statins, Omega-3, and Prostate Cancer: A Narrative Review.
    Kim H; Kim JK
    World J Mens Health; 2022 Jul; 40(3):412-424. PubMed ID: 35021299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish oil supplementation for management of dyslipidemia.
    Hessel JA
    Holist Nurs Pract; 2010; 24(4):223-6. PubMed ID: 20588131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia.
    Pirillo A; Catapano AL
    Atheroscler Suppl; 2013 Aug; 14(2):237-42. PubMed ID: 23958479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis.
    Eslick GD; Howe PR; Smith C; Priest R; Bensoussan A
    Int J Cardiol; 2009 Jul; 136(1):4-16. PubMed ID: 18774613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living in the Southern Hemisphere: Metabolic Syndrome and Its Components in Amazonian Riverine Populations.
    Arrifano GP; Alvarez-Leite JI; Macchi BM; Campos NFSS; Augusto-Oliveira M; Santos-Sacramento L; Lopes-Araújo A; Souza-Monteiro JR; Alburquerque-Santos R; do Nascimento JLM; Santos S; Ribeiro-Dos-Santos Â; Oriá RB; Crespo-Lopez ME
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study of fish oil supplementation on lipid traits in 81,246 individuals reveals new gene-diet interaction loci.
    Francis M; Li C; Sun Y; Zhou J; Li X; Brenna JT; Ye K
    PLoS Genet; 2021 Mar; 17(3):e1009431. PubMed ID: 33760818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oily Fish Consumption and the Risk of Dyslipidemia in Korean Adults: A Prospective Cohort Study Based on the Health Examinees Gem (HEXA-G) Study.
    Kim SA; Lee JK; Kang D; Shin S
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31627478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High potency fish oil supplement improves omega-3 fatty acid status in healthy adults: an open-label study using a web-based, virtual platform.
    Udani JK; Ritz BW
    Nutr J; 2013 Aug; 12():112. PubMed ID: 23924406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based and heuristic approaches for customization of care in cardiometabolic syndrome after spinal cord injury.
    Nash MS; Cowan RE; Kressler J
    J Spinal Cord Med; 2012 Sep; 35(5):278-92. PubMed ID: 23031165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia and pediatric obesity.
    Cook S; Kavey RE
    Pediatr Clin North Am; 2011 Dec; 58(6):1363-73, ix. PubMed ID: 22093856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying molecular effects of diet through systems biology: influence of herring diet on sterol metabolism and protein turnover in mice.
    Nookaew I; Gabrielsson BG; Holmäng A; Sandberg AS; Nielsen J
    PLoS One; 2010 Aug; 5(8):e12361. PubMed ID: 20808764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRalpha.
    Howell G; Deng X; Yellaturu C; Park EA; Wilcox HG; Raghow R; Elam MB
    Biochim Biophys Acta; 2009 Dec; 1791(12):1190-6. PubMed ID: 19716432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish oil in the treatment of dyslipidemia.
    Goldberg RB; Sabharwal AK
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):167-74. PubMed ID: 18316953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.